Sterne Kessler Building Interior

Deborah Sterling, Ph.D.

Director
Deborah Sterling

Deborah Sterling, Ph.D., is a director and co-chair of Sterne Kessler’s Biotechnology & Chemical Practice Group. Her practice is focused in the biotechnology and pharmaceutical industries, where she is involved in all areas of patent procurement, exploitation and enforcement. Deborah’s experience includes representing clients in over 70 inter partes review and covered business method proceedings, and in multiple patent interferences and reexaminations. Her practice also includes counseling clients on intellectual property strategy, including evaluating patent portfolios, e.g., for invalidity, non-infringement, freedom-to-operate and due diligence analyses, and she has assisted clients in devising design-around strategies for issued patents. Deborah has also been involved in multiple pharmaceutical and biotechnology patent litigations, including those brought under the Hatch-Waxman Act.

Deborah’s intellectual property experience has been principally in technical areas such as biotechnology, pharmaceuticals, molecular biology, analytical instruments, agrochemicals and clean technology. She has been recognized by Corporate LiveWire and was named Biotechnology Lawyer of the Year, Washington, D.C. for her work.

Deborah is a contributing author of Patent Office Litigation, Second Edition, published in 2017, and the two-volume set Patent Office Litigation, published in 2012 by Thomson Reuters Westlaw. The first edition focuses on the new contested proceedings under the America Invents Act, while the second edition provides a fresh and comprehensive exploration of these proceedings. Both books examine how the proceedings interact with other aspects of patent procurement and enforcement, and deliver practical analysis and advice. She is also a contributing author on the “Patentability Challenges at the U.S. Patent and Trademark Office” chapter in the Patent Litigation Strategies Handbook, 4th ed. published by the ABA in 2015.

Deborah is the Chairperson of the firm's Professional Development Committee.

Deborah earned her J.D. from George Mason University School of Law, her Ph.D. in molecular and cellular physiology from the University of Alberta, and her B.S., with first class honours, in biochemistry from Heriot-Watt University.

Achievements

  • Corporate LiveWire, "Biotechnology Lawyer of the Year - Washington, D.C." (2015)
  • Lawyer Monthly, "Women in Law Award - Biotechnology Category" (2016-2015)

Representative Matters

District Court
  • Carestream Health, Inc. v. Caliper Life Sciences, Inc. – W.D.Wis. – (favorable settlement for our client Caliper)
  • Caliper Life Sciences, Inc., et al. v. Carestream Health, Inc. – N.D.Cal. – (favorable settlement for our client Caliper)
  • Jazz Pharmaceuticals v. Amneal Pharmaceuticals – D.N.J. – (ANDA case: Xyrem)
  • Reckitt Benckiser LLC, et al v. Amneal Pharmaceuticals, LLC – D. NJ. (ANDA case: Delsym)
International Trade Commission
  • In re Lithium Silicate Materials and Products Containing the Same, ITC Investigation No 337-TA-911
Arbitration
  • Caliper Life Sciences, Inc. v. Fluidigm Corporation (arbitration)
Court of Appeals for the Federal Circuit
  • 15-1317: Appeal by Patent Owner of PTAB Final Written Decision in Inter Partes Review cancelling all claims; We represented Petitioner in the IPR; PTAB Decision affirmed
  • 15-1824: Appeal by Patent Owner of PTAB Final Written Decision in Inter Partes Reexamination cancelling all claims; We represented Requester in the reexam; PTAB Decision affirmed
Post-Grant Proceedings Petitioner:
  • IPR2016-01831: The Kingsford Products Company, LLC v. Creative Spark LLC
  • IPR2016-01608: BioEQ IP AG v. Genentech, Inc.
  • IPR2016-01582: Wockhardt Bio AG v. Janssen Oncology, Inc.
  • IPR2016-00678: IntelGenX Corp. v ICOS Corp.
  • IPR2016-00370: Wockhardt Bio AG. v. Jazz Pharmaceuticals, Inc.
  • IPR2015-01560: 10X Genomics, Inc. v. The University of Chicago
  • IPR2015-01558: 10X Genomics, Inc. v. RainDance Technologies, Inc.
  • IPR2015-01163: 10X Genomics, Inc. v. The University of Chicago
  • IPR2015-01162: 10X Genomics, Inc. v. The University of Chicago
  • IPR2015-01158: 10X Genomics, Inc. v. The University of Chicago
  • IPR2015-01157: 10X Genomics, Inc. v. The University of Chicago
  • IPR2015-01156: 10X Genomics, Inc. v. The University of Chicago
  • IPR2015-00547: Amneal Pharms. LLC, Par Pharms., Inc. v. Jazz Pharms., Inc.
  • IPR2015-00546: Amneal Pharms. LLC, Par Pharms., Inc. v. Jazz Pharms., Inc.
  • IPR2015-00545: Amneal Pharms. LLC, Par Pharms., Inc. v. Jazz Pharms., Inc.
  • IPR2015-00154: BioReference Labs., Inc.; GeneDx, Inc. v. Univ. Utah Research Found.
  • IPR2015-00152: BioReference Labs., Inc.; GeneDx, Inc. v. Univ. Utah Research Found.
  • IPR2014-01316: BioReference Labs., Inc.; GeneDx, Inc. v. Univ. Utah Research Found.
  • IPR2014-01315: BioReference Labs., Inc.; GeneDx, Inc. v. Myriad Genetics
  • IPR2014-01314: BioReference Labs., Inc.; GeneDx, Inc. v. Myriad Genetics
  • IPR2014-01313: BioReference Labs., Inc.; GeneDx, Inc. v. Myriad Genetics
  • IPR2014-01312: BioReference Labs., Inc.; GeneDx, Inc. v. Myriad Genetics
  • IPR2014-01311: BioReference Labs., Inc.; GeneDx, Inc. v. Univ. Utah Research Found.
  • IPR2014-01310: BioReference Labs., Inc.; GeneDx, Inc. v. Myriad Genetics
  • IPR2014-01301: BioReference Labs., Inc.; GeneDx, Inc. v. Myriad Genetics
  • IPR2014-01299: BioReference Labs., Inc.; GeneDx, Inc. v. Myriad Genetics
  • IPR2014-01298: BioReference Labs., Inc.; GeneDx, Inc. v. Myriad Genetics
  • IPR2014-01296: BioReference Labs., Inc.; GeneDx, Inc. v. Myriad Genetics
  • IPR2014-00876: Apotex Corp. v. VIIV Healthcare UK Limited
  • IPR2014-00581: Butamax Advanced Biofuels, LLC v. Gevo Inc.
  • IPR2014-00402: Butamax Advanced Biofuels, LLC v. Gevo Inc.
  • IPR2014-00250: Butamax Advanced Biofuels, LLC v. Gevo Inc.
  • IPR2014-00144: Butamax Advanced Biofuels, LLC v. Gevo Inc.
  • IPR2014-00143: Butamax Advanced Biofuels, LLC v. Gevo Inc.
  • IPR2014-00142: Butamax Advanced Biofuels, LLC v. Gevo Inc.
  • IPR2013-00539: Butamax Advanced Biofuels, LLC v. Gevo Inc.
  • IPR2013-00215: Butamax Advanced Biofuels, LLC v. Gevo Inc.
  • IPR2013-00214: Butamax Advanced Biofuels, LLC v. Gevo Inc.
  • CBM2014-00150: Amneal Pharms. LLC, et al. v. Jazz Pharms., Inc.
  • CBM2014-00149: Amneal Pharms. LLC, et al. v. Jazz Pharms., Inc.
Patent Owner:
  • IPR2017-00066: Reckitt Benckiser LLC v. Ansell Healthcare Products LLC
  • IPR2017-00063: Reckitt Benckiser LLC v. Ansell Healthcare Products LLC
  • IPR2016-01893: Kaz USA, Inc. v. Brita LP
  • IPR2016-01530: Forty Seven Inc. v. Stichting Sanquin Bloedvoorziening
  • IPR2016-01529: Forty Seven Inc. v. Stichting Sanquin Bloedvoorziening
  • IPR2016-00441: Aerospace Comms. Holdings Co., Ltd. v. IDQ Operating, Inc.
  • IPR2016-00442: Aerospace Comms. Holdings Co., Ltd. v. IDQ Operating, Inc.
  • IPR2012-00022: Ariosa Diagnostics v. Isis Innovation Limited.

Thought Leadership

Past Events

Contact Information

Phone Number

Education

J.D.
George Mason University School of Law
Ph.D.
Molecular and Cellular Physiology
University of Alberta
B.Sc.
Biochemistry
Heriot-Watt University
first class honours

Admissions

District of Columbia
New York
Supreme Court of the United States
U.S. Court of Appeals for the Federal Circuit
U.S. District Court for the District of Columbia
United States Patent & Trademark Office

Affiliations

  • American Bar Association
  • American Intellectual Property Law Association
  • New York Bar Association
  • Pauline Newman IP American Inn of Court
  • PTAB Bar Association